P
RL IS A multifunctional hormone secreted from the anterior pituitary gland, with over 300 known actions in mammalian tissues (1) . Under most conditions, PRL secretion is inhibited by dopamine that is released from neurosecretory neurons within the hypothalamus and acts on D2 receptors on the pituitary lactotrophs to inhibit PRL secretion (2) . The tuberoinfundibular dopamine (TIDA) neurons, located in the arcuate nucleus of the hypothalamus with terminals in the median eminence, represent the major source of dopamine in the hypophyseal portal blood (2) . In addition, it is thought that periventricular hypophyseal and tuberohypophyseal dopamine neurons, which release dopamine from terminals in the intermediate and posterior lobes of the pituitary, respectively, also contribute to the tonic inhibition of PRL secretion (2) . It is well established that PRL activates all three populations of hypothalamic dopamine neurons (3), thereby regulating its own secretion by short-loop negative feedback. PRL receptors are expressed on hypothalamic dopamine neurons (4 -6) , but the intracellular signaling pathway that is activated after PRL stimulation of these neurons is not known.
When PRL binds to its receptor, it simultaneously activates multiple intracellular signaling proteins, including those involved in Janus kinase-signal transducer and activator of transcription (STAT) pathways (1, 2) . Our investigations in mice lacking STAT5b revealed a pleiotropic phenotype with characteristics of PRL insensitivity, including impaired luteotropic support leading to spontaneous abortion during pregnancy and failure of milk production at parturition (7) . However, we also found signs of PRL excess, such as exaggerated lobulo-alveolar development and milk secretion in the mammary glands of nulliparous animals (Davey, H. W., et al., unpublished data). We hypothesized that these somewhat paradoxical observations might be explained by a failure of the negative feedback regulation of PRL secretion in STAT5b-deficient mice. Thus, although functions requiring PRL signaling through STAT5b would be impaired, the hyperprolactinemia resulting from a lack of negative feedback would cause increased PRL signaling through alternative intracellular signaling cascades, including pathways involving other STAT molecules or the MAPK pathway (1) . To test this hypothesis, we have investigated the neuroendocrine regulation of PRL secretion in STAT5b-deficient mice.
Materials and Methods Animals
The Stat5b gene was disrupted by the insertion of a neomycin resistance cassette into the codon for amino acid 181 using homologous recombination in embryonic stem cells. Details of the generation of these mice have been described previously (7) . Homozygous Stat5b Ϫ/Ϫ mice were bred by mating heterozygous females with homozygous Stat5b Ϫ/Ϫ males, whereas wild-type 129ϫBALB/c outcrossed mice were bred from wild-type parents. The Stat5b genotypes of all mice used in the experAbbreviations: AP-1, Activator protein 1; DOPAC, dihydroxyphenylacetic acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; STAT, signal transducer and activator of transcription; TIDA, tuberoinfundibular dopamine.
iments were determined by PCR using the following primers: forward primer (Stat5b gene), 5Ј-CCCAAGAGTACTTCATCATCCAG-3Ј; and reverse primers, wild-type allele (Stat5b gene), 5Ј-GAGCTTGCTC-CTACGACCTTACT-3Ј; Stat5b disrupted allele (PGK promoter), 5Ј TGACTAGGGGAGGAGTAGAAGGTGG 3Ј.
Male and female mice (ϳ5 months old, 26 -30 g) were selected at random and killed by CO 2 inhalation. Blood was collected by cardiac puncture, and brains were removed and either rapidly frozen in liquid nitrogen and stored at Ϫ80 C or immersion-fixed in 4% paraformaldehyde for 24 h, then stored in 70% ethanol. All procedures were approved by the Ruakura animal ethics committee.
RIA
Serum PRL concentrations were determined by RIA using reagents provided by Dr. A. F. Parlow through the National Hormone and Pituitary Program of the NIH. Purified mouse PRL (AFP10777D) was iodinated by the chloramine-T method and used at a concentration of 20,000 cpm/tube. Primary antiserum (AFP131078Rb) was added at a final tube dilution of 1:200,000. The reference preparation was mouse PRL (AEP-6476-C). The sensitivity of the assay, based on 15% displacement of the total radioactivity binding, was 0.25 ng/tube. All samples were run in a single assay, with an intraassay coefficient of variation of 7.4%.
Brain microdissection
Thick (300 m) frozen coronal sections through the brain were prepared in a cryostat at Ϫ9 C, thaw-mounted onto glass microscope slides, and immediately refrozen. Specific brain regions were microdissected from these slices using the punch technique (8) . All punches were collected with a microdissection needle of 500-m diameter. The median eminence was dissected from two consecutive sections using two overlapping punches. After removal of the median eminence, the arcuate nuclei were dissected bilaterally using a single punch centered on the third ventricle. The caudate putamen and substantia nigra were each dissected using bilateral punches from two consecutive sections (four punches in total). The arcuate nucleus and substantia nigra punches were placed into 300 l lysis buffer (Lysate RPA Kit, Ambion, Inc., Austin, TX), and the tissue was disrupted by sonication. The tissue lysate was then stored at Ϫ80 C until the mRNA levels were measured using a lysate ribonuclease protection assay. Median eminence and striatal tissue were placed into 50 l tissue buffer (0.05 m sodium phosphate and 0.03 m citric acid in 12% methanol, pH 3.0) for HPLC analysis. The tissue was disrupted by sonication, and then centrifuged at 10,000 ϫ g for 5 min. The supernatant was stored at Ϫ80 C until the catecholamine content was measured by HPLC. The remaining pellet was redissolved in 1 m NaOH, and the tissue protein content was measured (Protein Assay Kit, Bio-Rad Laboratories, Inc.) as an index of the amount of tissue in the dissection.
Lysate ribonuclease protection assay
Templates for riboprobes directed against mouse tyrosine hydroxylase mRNA were generated by RT-PCR from cDNA prepared from mouse brain tissue. Specific primers were designed with a phage promoter attached to their 5Ј-end, as described previously (9), and 33 Plabeled antisense riboprobes were synthesized using an in vitro transcription system (Promega Corp.). Mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control (template from Ambion, Inc.). The probes were added directly to the tissue lysate and hybridized overnight at 37 C. Ribonuclease was added to degrade unhybridized RNA (Lysate RPA Kit, Ambion, Inc.), and the protected double stranded fragments were precipitated and separated on a 5% nondenaturing polyacrylamide gel. Gels were dried and exposed to x-ray film for 18 -24 h, and the band intensities were quantified by densitometry (using NIH Image 1.61).
Immunohistochemistry
Paraformaldehyde-fixed brains were immersed overnight in a cryoprotectant solution (30% sucrose in 0.1 m phosphate buffer, pH 7.4), then rapidly frozen in isopentane cooled in liquid nitrogen. Coronal sections of 10 m were cut through the hypothalamus in a cryostat at Ϫ10 C and thaw-mounted onto 3-aminopropyltriethoxysilane-coated slides. Two adjacent brain sections were collected at intervals of 50 m throughout the arcuate nucleus, one for tyrosine hydroxylase immunostaining and the other for nonspecific immunostaining. Sections were immunostained using a rabbit polyclonal antibody directed against tyrosine hydroxylase (1:3000 dilution; AB151, Chemicon International, Inc., Temecula, CA), followed by the avidin-biotin complex method, as described previously (10) . Tyrosine hydroxylase-like immunoreactivity was visualized using diaminobenzidine as the chromogen. Throughout each staining procedure, one wild-type and one STAT5b-deficient brain of the same sex were processed in parallel. There was no significant staining of sections when the primary antibody was replaced with normal rabbit serum.
HPLC
Concentrations of dopamine and dihydroxyphenylacetic acid (DOPAC) were measured by isocratic HPLC with electrochemical detection. The mobile phase consisted of tissue buffer (see above) containing 0.015% octane sulfonic acid and 0.1 mm EDTA (pH 3.0), and was passed through a C 18 reverse phase column (Luna 3 m, 150 ϫ 4.6 mm, Phenomenex New Zealand, Ltd., Auckland, New Zealand) at 1 ml/min. Catecholamines were detected using a conditioning cell (ϩ350 mV) and a dual electrode analytical cell (model 5011, ESA, Bedford, MA) with electrodes set at Ϫ150 and ϩ350 mV. Changes in current at the second analytical electrode were measured by an electrochemical detector (Coulochem II, ESA). Dopamine and DOPAC were quantified by comparison with external standards. All values were corrected for the total protein content in the tissue punches.
Statistical analysis
All data are presented as the mean Ϯ sem. For serum PRL concentrations, comparisons between groups were made by ANOVA, followed by Fisher's protected least significant difference post-hoc test. The mRNA data were normalized using the ratio of tyrosine hydroxylase mRNA to GAPDH mRNA. DOPAC concentrations are presented as nanograms of DOPAC per g tissue protein. Normalized data were compared using the Mann-Whitney U test for nonparametric data. All statements of statistical significance refer to a probability level of less than 5% (i.e. P Ͻ 0.05).
Results

Serum PRL levels in STAT5b-deficient mice
In both males and females, serum PRL concentrations were grossly elevated (Ͼ10-fold) in STAT5b-deficient mice compared with age-and sex-matched wild-type mice (Fig. 1) . In addition, females had approximately 2-fold higher serum PRL levels than males. This sex difference was also found in wild-type mice, albeit at lower levels, and is consistent with previous findings (11) . Treatment with the dopamine D2 agonist bromocriptine markedly suppressed serum PRL levels in both male and female STAT5b-deficient mice to a level that was not significantly different from that in wild-type mice (Fig. 1) . This suggested that the high PRL levels observed in mice lacking STAT5b were not due to pituitary insensitivity to dopamine, but to an absence of endogenous dopaminergic inhibition from the TIDA neurons. The apparent failure of bromocriptine to significantly suppress mean serum PRL levels in the wild-type female mice (Fig. 1) reflects aberrantly high values in two individual mice.
TIDA neuronal activity in STAT5b-deficient mice
Tyrosine hydroxylase is the rate-limiting enzyme for dopamine synthesis. In brain regions such as the hypothalamus, in which dopaminergic neurons are the only catecholamine-producing neurons, tyrosine hydroxylase serves as a marker for dopaminergic neurons (12) . The levels of tyrosine hydroxylase mRNA in the arcuate nucleus reflect TIDA neuronal activity and increase in response to PRL (13) (14) (15) (16) . Hence, we used a lysate ribonuclease protection assay to quantify the level of tyrosine hydroxylase mRNA within the microdissected arcuate nucleus as an index of expression in the TIDA neurons. Tyrosine hydroxylase mRNA expression in the arcuate nucleus was significantly lower in STAT5b-deficient compared with wild-type mice (Fig. 2) . In contrast, there was no significant difference between STAT5b-deficient and wild-type mice in the levels of tyrosine hydroxylase mRNA in the substantia nigra pars compacta, which contains the neuronal cell bodies of the nigrostriatal dopaminergic pathway.
Immunohistochemistry was used to visualize tyrosine hydroxylase expression in the cell bodies of the TIDA neurons in the arcuate nucleus and in dopaminergic nerve terminals in the median eminence (n ϭ 3 mice of each sex and genotype). Although the distribution of TIDA neurons was similar in wild-type and STAT5b-deficient mice (Fig. 3, A and B) , the levels of tyrosine hydroxylase immunoreactivity were markedly lower in STAT5b-deficient mice (Fig. 3E ) than in wild-type mice (Fig. 3C) . In contrast, tyrosine hydroxylase immunoreactivity in the zona incerta, which is visible in the same sections as the arcuate nucleus, was not different between STAT5b-deficient and wild-type mice (Fig. 3, D and F) . There was no apparent difference between males and females of either genotype. These observations suggested that tyrosine hydroxylase expression was selectively reduced in the TIDA neurons of STAT5b-deficient mice.
Dopamine nerve terminals in the median eminence contain specific dopamine transporters that take up a proportion of released dopamine into the axon terminals (17) . This captured dopamine is rapidly metabolized in the median eminence to DOPAC, and thus, measurement of DOPAC provides an index of TIDA neuronal activity (18) . Concentrations of DOPAC in the median eminence of STAT5b-deficient females were significantly lower than in wild-type female mice (Fig. 4) , suggesting that dopamine release from TIDA neurons was markedly reduced in the STAT5b-deficient mice. DOPAC concentrations were also measured in the striatum, the nerve terminal region of the well characterized nigrostriatal dopaminergic pathway (19) . There were no differences in striatal DOPAC concentrations between STAT5b-deficient and wild-type female mice (Fig. 4) . The suppression of dopamine release in the absence of STAT5b was therefore selective to the hypothalamic TIDA neurons.
Discussion
The activity of TIDA neurons is normally very sensitive to the concentration of PRL circulating in the blood, such that an increase in PRL results in the increased synthesis and secretion of dopamine in mice (20, 21) and rats (14, 22, 23) . In the absence of STAT5b, however, the TIDA neurons appear to be unresponsive to PRL. Despite the markedly elevated PRL concentrations in the blood of STAT5b-deficient FIG. 1. Serum PRL concentrations (mean Ϯ SEM) in wild-type (ϩ/ϩ) female (n ϭ 11) and male (n ϭ 10) mice and STAT5b-deficient (Ϫ/Ϫ) female (n ϭ 11) and male (n ϭ 10) mice. Additional groups of mice were administered bromocriptine (BC; 100 g, sc, every 12 h for 3 d; n ϭ 6 of each sex and genotype). *, Significantly increased compared with wild-type mice; †, significantly different from non-BC-treated mice of the same sex and genotype; ‡, significantly different from female mice of the same genotype (by ANOVA, followed by Fisher's protected least significant difference post-hoc test, P Ͻ 0.05).
FIG. 2. Tyrosine hydroxylase (TH) mRNA expression in female
STAT5b-deficient (Ϫ/Ϫ; n ϭ 9) and wild-type (ϩ/ϩ; n ϭ 8) mice. The mRNA fragments that are protected by the TH (548 bp) and GAPDH (433 bp) probes in the arcuate nucleus and substantia nigra pars compacta are shown in representative gels in A. The ratio of TH mRNA to GAPDH mRNA (mean Ϯ SEM), are summarized in B. *, Significantly different from wild-type mice (Mann-Whitney U test for nonparametric data, P Ͻ 0.05).
mice, the TIDA neurons express less tyrosine hydroxylase and secrete less dopamine than in the wild-type mice. Administration of a dopamine agonist, bromocriptine, resulted in the reduction of serum PRL concentrations to a low level that was similar in both STAT5b-deficient and wild-type mice, indicating that the inhibition of pituitary PRL secretion by dopamine was unaffected by STAT5b deficiency. These data suggest that STAT5b specifically mediates the negative feedback action of PRL on TIDA neurons.
The phenotypes resulting from several mouse gene disruption experiments have emphasized the relationship between dopamine and PRL. Chronic elevation in PRL secretion occurs in mice lacking a functional D2 dopamine receptor (24, 25) due to an absence of inhibition in the pituitary gland. Similarly, serum PRL levels are markedly elevated in PRL receptor-deficient mice (26) , presumably due to lack of feedback stimulation of TIDA neurons (27) . Conversely, mice lacking the dopamine transporter, which normally removes extracellular dopamine and thus terminates dopamine signaling, are incapable of nursing their young (28) and exhibit suppressed PRL secretion (17) . Although such phenotypes could have been predicted from what was previously known about the negative feedback regulation of PRL secretion, our observation of hyperprolactinemia and low TIDA activity in STAT5b-deficient mice is unexpected. In different tissues, PRL signaling occurs through a variety of intracellular pathways, including STAT1, STAT3, STAT5a, and STAT5b, as well as a number of signaling cascades not involving the STAT proteins (1, 2). Hence, it was reasonable to expect a certain amount of redundancy in PRL signaling pathways in TIDA neurons. In particular, we expected that the highly homologous STAT5a protein, which shares 96% amino acid identity with STAT5b (29), might be able to compensate for the absence of STAT5b. This did not appear to happen. Indeed, serum PRL levels in mice lacking STAT5a are normal (30) , further demonstrating the specificity of the role of STAT5b in this pathway.
The elevated levels of serum PRL in PRL receptor-deficient mice (27) demonstrate the requirement for functional PRL receptors in the regulation of serum PRL concentrations. We have not measured PRL receptor expression in TIDA neurons, but we have data from other tissues that provide strong evidence for functional PRL receptors in STAT5b-deficent mice. In liver, Northern analysis showed that PRL receptor mRNA levels were similar in STAT5b-deficient and wildtype females, whereas in males there was an increase in PRL receptor expression in STAT5b-deficient mice (7) . The most compelling evidence for functional PRL receptors is the precocious lobuloalveolar development in the mammary glands of nulliparous mice, which results from the hyperprolactinemia and is evident from 6 wk of age (Davey, H. W., et al., unpublished data). Although there is some evidence for decreased expression of PRL receptors in mammary gland epithelial cells, we showed that PRL induced milk protein expression in mammary gland explant cultures and induced ductal branching in whole organ cultures (Davey, H. W., et al., unpublished data).
Gene disruption studies have indicated that there may be both distinct and redundant functions for STAT5a and STAT5b (7, (31) (32) (33) , but conclusions from the phenotypes of these mice are confounded by differences in the expression of Stat5a and Stat5b in various tissues (29, 34) . Thus, there are at least two alternative explanations for the PRL resistance observed in the TIDA neurons in STAT5b-deficient mice. First, Stat5b may be expressed at much higher levels than Stat5a, as is found in the liver (34) , so that the amount of STAT5a alone is insufficient to transduce the PRL-initiated signal. Second, STAT5b may have a specific role in mediating PRL signaling in these neurons that cannot be compensated for by other STAT proteins. Regardless of the specific mechanism involved, our results clearly show that STAT5b is absolutely required for PRL signaling in TIDA neurons and that STAT5b deficiency results in hyperprolactinemia. Hence, the paradox of the STAT5b-deficient phenotype, which shows specific defects in PRL signaling as well as signs of PRL excess, is explained by our data.
There have been few previous studies of the PRL signal transduction pathways in the brain. Although PRL has been shown to stimulate the translocation of STAT5 from the cytoplasm to the nucleus in TIDA neurons (35) , direct involvement of STAT5 in the induction of tyrosine hydroxylase gene expression has not been demonstrated. The tyrosine hydroxylase 5Ј-flanking DNA contains a number of potential STAT5-binding sites with the most proximal consensus binding site at about Ϫ1 kb relative to the start of transcription (GenBank accession no. AF014956 rat, X53503 mouse) (36) . Additionally, tetrameric STAT5 proteins may well interact with some of the low affinity binding sites (37) and increase transcription from the tyrosine hydroxylase gene. Other potentially important promoter elements in the tyrosine hydroxylase gene include binding sites for activator protein 1 (AP-1), AP-2, SP1, the cAMP response element, Ptx1/3, Nurr1, and Glil1/2 as well as an E box, the Oct/HEPT motif, a GT dinucleotide repeat, and a neural restrictive silencer element (38 -43) . It is possible that STAT5b may also induce tyrosine hydroxylase expression indirectly through one or more of these sites. For example, there is a STAT5-binding site in the promoter of the c-fos gene, and c-Fos has been implicated in PRL regulation of TIDA neurons (44 -46) , presumably acting at the AP-1 site in the tyrosine hydroxylase promoter.
Although our data provide compelling evidence implicating STAT5b in mediating PRL signaling in TIDA neurons, it is unknown whether this would hold true for other neuronal populations that express PRL receptors (10, (47) (48) (49) (50) . PRL is involved in regulating a number of hypothalamic functions, including stimulation of food intake (51, 52) , and maternal behavior (53, 54) . It would be interesting to determine whether STAT5b is also obligatory for these other actions of PRL in the brain.
The data presented above provide the first description of the specific intracellular pathways mediating PRL negative feedback in the hypothalamus, and as such represent a fundamental advance in our understanding of this important neuroendocrine regulatory mechanism. In addition, they provide novel evidence of a surprising specificity of different STAT proteins within neuronal signal transduction pathways.
